Daniel Grosslight
Stock Analyst at Citigroup
(1.91)
# 3,057
Out of 4,876 analysts
96
Total ratings
38.33%
Success rate
-9.29%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Initiates: Buy | $45 | $39.76 | +13.18% | 1 | Jun 25, 2025 | |
| CAH Cardinal Health | Maintains: Neutral | $157 → $170 | $165.51 | +2.71% | 6 | Jun 13, 2025 | |
| HIMS Hims & Hers Health | Maintains: Sell | $25 → $30 | $50.71 | -40.84% | 11 | May 6, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $7 → $6.5 | $3.83 | +69.71% | 9 | Apr 25, 2025 | |
| TDOC Teladoc Health | Maintains: Neutral | $11 → $8.75 | $8.82 | -0.79% | 11 | Apr 25, 2025 | |
| AGL agilon health | Upgrades: Buy | $3.25 → $5 | $2.29 | +118.34% | 5 | Apr 25, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $13 → $11 | $8.38 | +31.34% | 6 | Apr 17, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $10.91 | +64.99% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $5.00 | +25.00% | 7 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $724.25 | -6.52% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $35 | $28.20 | +24.11% | 6 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $21.99 | +13.69% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $4.22 | +136.97% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $11.01 | -27.34% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $2.32 | -46.00% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $2.77 | +26.35% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $9.37 | +38.74% | 1 | Dec 11, 2019 |
Waystar Holding
Jun 25, 2025
Initiates: Buy
Price Target: $45
Current: $39.76
Upside: +13.18%
Cardinal Health
Jun 13, 2025
Maintains: Neutral
Price Target: $157 → $170
Current: $165.51
Upside: +2.71%
Hims & Hers Health
May 6, 2025
Maintains: Sell
Price Target: $25 → $30
Current: $50.71
Upside: -40.84%
Health Catalyst
Apr 25, 2025
Maintains: Buy
Price Target: $7 → $6.5
Current: $3.83
Upside: +69.71%
Teladoc Health
Apr 25, 2025
Maintains: Neutral
Price Target: $11 → $8.75
Current: $8.82
Upside: -0.79%
agilon health
Apr 25, 2025
Upgrades: Buy
Price Target: $3.25 → $5
Current: $2.29
Upside: +118.34%
Owens & Minor
Apr 17, 2025
Maintains: Buy
Price Target: $13 → $11
Current: $8.38
Upside: +31.34%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $10.91
Upside: +64.99%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $5.00
Upside: +25.00%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $724.25
Upside: -6.52%
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $28.20
Upside: +24.11%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $21.99
Upside: +13.69%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $4.22
Upside: +136.97%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $11.01
Upside: -27.34%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $2.32
Upside: -46.00%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $2.77
Upside: +26.35%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $9.37
Upside: +38.74%